Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN116478155A enables high-purity Grapiprant production with significant cost reduction and supply chain reliability for veterinary pharmaceutical manufacturers.
Patent CN109136298B reveals a dual-enzyme membrane separation process for D-amino acids, offering >99.9% e.e. and scalable green manufacturing solutions.
Patent CN108329194B reveals a novel binaphthol aluminum catalyst for citronellal cyclization, offering superior enantioselectivity and simplified industrial recovery.
Patent CN104557583A reveals green quinidine catalysis for high-purity pharmaceutical intermediates ensuring cost reduction and supply chain reliability.
Patent CN106928136B details graphene palladium cobalt catalysis for montelukast intermediate. Offers high yield and chiral selectivity for reliable pharmaceutical intermediate supply chains.
Patent CN100503590C details a novel Rh-catalyzed hydrogenation of L-malic acid diester. This method offers high optical purity and lower pressure conditions for efficient API intermediate manufacturing.
Patent CN114315627B introduces a green ionic liquid-zeolite method for doxycycline intermediates, offering high purity and reduced environmental impact for pharma supply chains.
Patent CN115160113B reveals efficient dual synthesis. Reduces costs and improves supply chain reliability for fragrance manufacturers.
Patent CN114349754B details a high-yield ionic liquid method for 2,6-dichloropurine, offering pharmaceutical intermediate suppliers a greener, heavy-metal-free production route.
Patent CN103408502A details a Bronsted acid-catalyzed, metal-free route to quinazolinones using O2. This method ensures high purity and significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN103059010B reveals high-yield antifungal synthesis. Enables cost reduction in fungicide manufacturing with scalable water-based processes.
Patent CN104086487B reveals ionic liquid method for caprolactam. Reduces waste and cost. Reliable supply chain solution for polymer and pharma intermediates.
Patent CN112795603B reveals a high-efficiency IRED method for chiral pyrrolidines, offering superior purity and green manufacturing advantages.
Patent CN103664599A details a green esterification route for TMPTA using molecular sieves and alkanes, achieving >98% purity and >95% yield for coating applications.
Patent CN102277320B reveals enzymatic IDA synthesis reducing waste. Discover cost-effective, high-purity agrochemical intermediate solutions for glyphosate production.
Patent CN101701243B details a high-efficiency biocatalytic route for R-mandelic acid using Alcaligenes faecalis, offering superior purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN116023401B reveals mild photoredox synthesis for chiral borates. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Advanced Wittig reaction protocol for high-purity cephalosporin intermediates. Optimized Z-isomer selectivity and scalable manufacturing for oral antibiotics.
Patent CN116023401B reveals mild photoredox nickel catalysis for chiral borates. Enables high purity pharmaceutical intermediates with reduced cost and scalable supply chain reliability.
Advanced patent-based synthesis of Etimicin sulfate offers higher purity and yield. Discover cost-effective manufacturing and reliable supply chain solutions for antibiotic production.